Navigation Links
Rules-Based Medicine, Inc. Names Tony Barnes to Lead Expanding Diagnostics Business
Date:6/2/2009

AUSTIN, Texas, June 2 /PRNewswire/ -- Rules-Based Medicine, Incorporated (RBM), the leading biomarker testing service, today announced that Tony Barnes, Ph.D., MBA, has joined the Company as vice president, clinical diagnostics. Barnes will provide strategic marketing and operational leadership as RBM commercializes new biomarker-based diagnostic tests.

RBM, an established provider of multiplex biomarker assays for improved drug development, has programs to develop new diagnostic products targeting disease categories that currently lack accurate and objective tests. Commercialization programs underway include tests for schizophrenia and kidney disease. The Company has access to interesting and novel biomarker technology through partnerships with multiple companies and institutions, including companion diagnostic programs with major pharmaceutical companies.

Barnes brings to the Company 25 years experience in business development, senior management, marketing, operations and program management, gained at leading healthcare companies, such as Abbott Diagnostics, LifeScan Inc., and Ciba Corning Diagnostics. He also served as a strategic consultant for Booz Allen and Hamilton and consulted directly to major healthcare companies such as Ortho Pharma and Bristol-Myers Squibb.

Most recently, Barnes served as co-founder, chief executive officer and vice chairman of Oncimmune Ltd. During his six years with the company, Barnes developed and managed comprehensive technical, marketing and operations plans for the company and led the establishment of both the U.K. parent and U.S. subsidiary businesses. The first Oncimmune product, EarlyCDT-Lung(TM), a test for the early detection of lung cancer was launched in May 2009.

"As we establish new processes and infrastructure around our diagnostic programs, the additive value of Tony's extensive development, marketing, and operational experience will only strengthen our effort," said Craig Benson, RBM chief executive officer. "We are pleased to have him on board and welcome his insight and energy."

"RBM is positioned to accelerate the development of exciting and necessary diagnostic tests," said Barnes. "The Company is on the leading edge of multiplex assay technology that has the potential to enhance patient care. I look forward to working with the RBM management team and our collaborators to advance that vision."

About Rules-Based Medicine, Inc.

Rules-Based Medicine (RBM) provides comprehensive protein biomarker products and services centered on its Multi-Analyte Profiling (MAP) technology. Its service platform (RodentMAP(R) and HumanMAP(R)) provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins cost-effectively in multiple species, and from a small sample volume. The Company also offers innovative and proprietary ex vivo testing systems such as TruCulture(TM), the first fully-closed, reproducible whole blood culture system. RBM is actively developing multiplex diagnostic tests to detect the presence of complex diseases and conditions in areas of unmet medical need such as neuropsychiatry, nephrology, immunology and cardiology. More information about RBM is located at www.rbmmaps.com.

RodentMAP(R) and HumanMAP(R) are registered trademarks of Rules-Based Medicine Inc.


'/>"/>
SOURCE Rules-Based Medicine, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hofstra University to Establish New School of Medicine, Partnering with the North Shore-LIJ Health System
2. Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks
3. Tip sheet for the Annals of Internal Medicine, April 15, 2008, issue
4. Elsevier expands Procedures Consult with emergency medicine, orthopedics and anesthesia procedures
5. McGraw-Hill Professional Redesigns AccessMedicine, Highlighting Media and Educational Features
6. AMD Global Telemedicine, Inc. Forms Telemedicine Design Group
7. Healthcare Reform Should Include Connected Health and Participatory Medicine, Says Report Submitted to President Obama by Center for Connected Health
8. McGraw-Hill Professional and JAMA Launch New Online Evidence-Based Medicine, Clinical and Educational Resource
9. Local Infertility Specialist, Dr. Rachel Bennett, Westchester Reproductive Medicine, Opens New Office in Mount Kisco
10. AMD Global Telemedicine, Inc is Pleased to Announce the Selection of its Examination Camera for the Canadian National Telehealth Videoconference Equipment RFP
11. Penn Medicine, CHOP researchers demonstrate first common genetic risk factors for autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, ... organization dedicated to helping service members that have been wounded in battle and their ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Dublin ... the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global market ... its applications in various applications. The report deals with ... main industries: pharmaceutical and biotechnology, food and beverage, and ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: